Insiders Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:37 2025-06-19 EDT			5-day change	1st Jan Change
95.21 ^CHF	+0.25%		-2.92%	+7.34%

06-19	NOVARTIS AG : Deutsche Bank maintains a Buy rating	ZD
06-19	Swiss trade surplus at CHF 3.831 bln in May	RE

Insiders

Rocket Pharmaceuticals, Inc Appoints Sarbani Chaudhuri as Chief Commercial & Medical Affairs Officer, Effective from April 7, 2025	04-07	CI
Kalaris Therapeutics, Inc. Appoints Leone Patterson to Its Board of Directors and as Chair of the Board?s Audit Committee	04-04	CI
Novo Nordisk's head of commercial strategy steps down	04-03	RE
Transgene SA Appoints Simone Steiner as Chief Technical Officer	04-01	CI
Deutsche Bank: Kirsty Roth, Klaus Moosmayer proposed to join supervisory board	03-31	RE
Deutsche Bank: Kirsty Roth, Klaus Moosmayer proposed to join supervisory board	03-31	RE
Novartis Adds Compliance Function to Chief Legal Officer Role	03-31	MT
Novartis Appoints Karen Hale Chief Legal And Compliance Officer	03-31	RE
Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis	03-31	DJ
Novartis Announces Executive Changes	03-31	CI
Immuneering Names Dr. Igor Matushansky, MD, PhD, as Chief Medical Officer	03-20	CI
Novartis Named Official Pharmaceutical Partner of US' National Football League	03-14	MT
Novartis AG Approves Board Changes	03-07	CI
Novartis Stockholder Sandoz to Reportedly Sell 26.5 Million Shares	02-26	MT
PRESS DIGEST-Financial Times - February 12	02-11	RE
Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare	01-21	MT
Banzai International, Inc. Appoints Nancy Norton as Chief Legal Officer	12-18	CI
Maeve Waldron-Lynch to Join Tango Therapeutics, Inc. as Senior Vice President, Head of Clinical Development	11-06	CI
NovoCure Limited Appoints Christoph Brackmann as Senior Financial Advisor	24-10-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

NOVARTIS : Q1 ahead of expectations; outlook revised higher

April 29, 2025 at 07:58 am

Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare

January 21, 2025 at 03:33 pm

Novartis AG : Sandoz takes its first steps on the stock exchange

October 04, 2023 at 10:32 am